A new proprietary analysis of cutting-edge Alzheimer's drugs finds growing excitement around experimental therapies targeting ...

A large health-record analysis found that glucosamine use was associated with a 25% higher likelihood of mild cognitive ...

Researchers have uncovered a surprising immune-system switch in the brain that could open a new avenue in the fight the ...

Ultrahigh-performance liquid chromatography–tandem mass spectrometry (UHPLC–MS/MS) tracks blood metabolite changes after repetitive transcranial magnetic stimulation (rTMS)-cognitive training therapy.

Researchers at Washington University School of Medicine in St. Louis have developed a potential antibody-based approach to ...

Jeremy Scott told Newsweek he remembers having a strange experience at a Disney resort years before his diagnosis.

Alzheimer’s disease (AD) is a heterogeneous disorder with multiple etiologies. Harnessing the immune system by blocking the programmed cell death receptor (PD)-1 pathway in an amyloid beta mouse model ...

What can mathematics reveal about Alzheimer's disease? Mississippi State University associate professor Shantia Yarahmadian ...

Two years is a fairly typical length of time for people with symptoms to receive a diagnosis of Alzheimer’s, even though ...

Communities took part in the annual fundraising event to support local and global Alzheimer's programs ...

Over the past weekend, a wealth of Green Bay residents came together for the annual Green Bay Walk to End Alzheimer’s, ...